NCT01413178
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Neoplasms, Plasma Cell
Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.
512 public trials
52 recruiting studies
Neoplasms, Plasma Cell trial results
NCT02598752
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +18 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT01497093
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT01245673
- Conditions
- Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
- Locations
-
- University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT00003687
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
- Princess Margaret Hospital Toronto, Ontario, Canada
- McGill University Montreal, Quebec, Canada
NCT00006890
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- St. Mary's/Duluth Clinic Health System Duluth, Minnesota, United States
- Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
- Lethbridge Cancer Clinic Lethbridge, Alberta, Canada
- Burnaby Hospital Regional Cancer Centre Burnaby, British Columbia, Canada
NCT00002678
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- St. Mary's/Duluth Clinic Health System Duluth, Minnesota, United States
- Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
- Cross Cancer Institute Edmonton, Alberta, Canada
- British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada
NCT02356549
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States
Completed
Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma
NCT01023308
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Novartis Investigative Site Phoenix, Arizona, United States
- Novartis Investigative Site Anaheim, California, United States
- Novartis Investigative Site Concord, California, United States
- Novartis Investigative Site Los Angeles, California, United States
NCT00053989
- Conditions
- Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +67 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States